Furthermore, CD14+ monocytes from AD patients who carried the combination of ALDH2*1/*2 and ADH1B*2 genotypes, the most acetaldehyde-exposed group, produced the lowest amount of TNF-α in response to LPS stimulation compared to that in patients with the three other genotypic patterns on admission (Fig. 3A). This evidence concerns the gene CD14 and Alzheimer disease.